SCHEMBL7217495

SCHEMBL7217495

CC(=O)Nc1ccc2[nH]cnc(=O)c2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.52
ALDH1A1 P00352 3/20 0.52
HPGD P15428 3/20 0.52
ESR1 P03372 1/20 0.52
MTNR1A P48039 2/20 0.51
MTNR1B P49286 2/20 0.51
KMT2A Q03164 1/20 0.51
ERCC1 P07992 2/20 0.50
FEN1 P39748 2/20 0.50
ERCC4 Q92889 2/20 0.50
DNASE1 P24855 1/20 0.50
ROCK2 O75116 1/20 0.48
ROCK1 Q13464 1/20 0.48
CHEK1 O14757 1/20 0.47
HTR1A P08908 1/20 0.46
HTR1D P28221 1/20 0.46
HTR1B P28222 1/20 0.46
HTR1F P30939 1/20 0.46
MAOA P21397 2/20 0.45
ALOX15 P16050 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL839649 0.80 KDM4E (0.54) KDM4EALDH1A1HPGDESR1MTNR1A
Hydrochloric Acid SCHEMBL2397058 0.79 KDM4E (0.53) KDM4EALDH1A1HPGDESR1MTNR1A
SCHEMBL6886180 0.78 XDH (0.36) KDM4EALDH1A1HPGDKMT2ACHEK1
SCHEMBL11580425 0.77 QPCT (0.63)
SCHEMBL7217498 0.77 SLC2A1 (0.67) KDM4EALDH1A1HPGDESR1KMT2A
SCHEMBL18343659 0.76 KDM4E (0.62) KDM4EALDH1A1HPGDESR1MTNR1A
SCHEMBL18343655 0.75 KDM4E (0.52) KDM4EALDH1A1HPGDESR1MTNR1A
SCHEMBL8304643 0.73 HTR1D (0.50) KDM4EALDH1A1HTR1AHTR1DHTR1B
SCHEMBL2574527 0.73 LMNA (0.57) KDM4EALDH1A1HPGDKMT2AROCK2
SCHEMBL1507612 0.73 PARP1 (0.54) KDM4EALDH1A1HPGDKMT2ACHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6596726-B1 Method of inhibiting epidermal growth factor by treating, with an effective inhibiting amount, a mammal, in need thereof inhibit the epidermal growth factor receptor and related receptors and, in particular, their tyrosine kinase enzyme WARNER LAMBERT COMPANY 2003-07-22 US disclosed
US-5679683-A USEFUL FOR TREATING CANCER, ARTHRITIS, PSORIASIS, VASCULAR RESTENOSIS AND ANGIOGENESIS WARNER-LAMBERT COMPANY (US) 1997-10-21 US disclosed
EP-0741711-A1 TRICYCLIC COMPOUNDS CAPABLE OF INHIBITING TYROSINE KINASES OF THE EPIDERMAL GROWTH FACTOR RECEPTOR FAMILY WARNER-LAMBERT COMPANY (US) 1996-11-13 EP disclosed
WO-1995019970-A1 TRICYCLIC COMPOUNDS CAPABLE OF INHIBITING TYROSINE KINASES OF THE EPIDERMAL GROWTH FACTOR RECEPTOR FAMILY WARNER-LAMBERT COMPANY (US) 1995-07-27 WO disclosed